N@N

UACL, SBCF, ASIA, GILD, THRX, ULGX Expected To Be Down After Next Earnings Releases

April 25, 2012 / M2 PRESSWIRE / BUYINS.NET / www.squeezetrigger.com is monitoring the performance of all stocks with earnings being released Thursday, April 26th 2012 and determining how the stocks have performed After their last 12 quarterly, 6 quarterly and June earnings reports. UNIVERSAL TRUCKLOAD SERVICES (NASDAQ:UACL), SEACOAST BANKING CORP/FL (NASDAQ:SBCF), Asiainfo Linkage Inc (NASDAQ:ASIA), GILEAD SCIENCES, INC. (NASDAQ:GILD), THERAVANCE, INC. (NASDAQ:THRX), Urologix Inc (NASDAQ:ULGX) are all expected to be Down After their earnings are released. The movement of stock prices in the days and weeks leading to and following these earnings announcements may follow a predictable pattern. Most companies stock price histories show random or unpredictable movements around earnings dates. But some seem to repeat the same pattern quarter after quarter, year after year. The # of Reports in the table below shows how many previous quarterly reports comprise the indicator that predicts how a stock will act after its earnings are released. The specific technology used to make these predictions is available for a low monthly fee at http://www.squeezetrigger.com/services/strat/mh.php . The following stocks are expected to go Down After earnings are released Thursday:

  Symbol  Company                          # of Reports         Quarter  Release Time
  UACL    UNIVERSAL TRUCKLOAD SERVICES     6 Quarter            Q1       After
  SBCF    SEACOAST BANKING CORP/FL         6 Quarter            Q1       After
  ASIA    Asiainfo Linkage Inc             6 Quarter            Q1       After
  GILD    GILEAD SCIENCES, INC.            6 Quarter            Q1       After
  THRX    THERAVANCE, INC.                 6 Quarter            Q1       After
  ULGX    Urologix Inc                     12 Quarter           Q3       After

This technology is designed to help the stock trader identify those companies that seem to have a consistent pattern of movement before or after the earnings release date, based on the history of earnings releases for that company. It combines a calendar of expected earnings releases with a history of past earnings releases in a way that lets you see if a pattern exists.

UNIVERSAL TRUCKLOAD SERVICES (NASDAQ:UACL) - Universal Truckload Services, Inc., through its subsidiaries, operates as an owner-operator and agency based truckload motor carrier in the United States and in the Canadian provinces of Ontario and Quebec. It offers over-the-road trucking services, including flatbed and dry van operations, and rail-truck and steamship-truck intermodal support services, as well as truck brokerage services. The company transports various general commodities comprising machinery, building materials, paper, food, consumer goods, automotive parts, furniture, steel, and other metals. It also involves in the brokerage of freight to third party transportation providers, such as competing truckload carriers, and shipper-owned and operated private motor carrier transport fleets. In addition, the company offers intermodal support services comprising short-to-medium distance delivery of rail and steamship containers between the railhead or port and the customer, as well as drayage services. Universal Truckload primarily operates through a contractor network of agents and owner-operators. It provides its services to various shippers in the automotive and steel industries, and other transportation companies who aggregate loads from various shippers. The company was founded in 1981 and is headquartered in Warren, Michigan.

SEACOAST BANKING CORP/FL (NASDAQ:SBCF) - Seacoast Banking Corporation of Florida operates as the holding company for Seacoast National Bank that provides various financial products and services in the United States. It offers a range of deposit accounts and retail banking services; engages in consumer and commercial lending; and provides various trust and asset management services. The company also offers Internet banking, and brokerage and annuity services. As of December 31, 2008, it had 42 banking offices in 14 counties. The company was founded in 1926 and is based in Stuart, Florida.

Asiainfo Linkage Inc (NASDAQ:ASIA) - AsiaInfo-Linkage, Inc. provides telecommunications software solutions, and information technology (IT) security products and services for telecommunications service providers, as well as to other enterprises in China. Its AsiaInfo Technologies division provides software products and services, which enable customers to build, maintain, operate, manage, and continuously enhance their communications infrastructure and services in the telecom market. This divisions products and services to the telecommunications industry, primarily to China's telecom carriers, include various software product suites, each of which is given the name of Open because the software installed is designed with open architecture to facilitate further development and customization for specific purposes. It integrates a combination of these products, together with various services, into customized solutions that address individual customer needs. The companys Lenovo-AsiaInfo division offers IT security products, such as firewall and virtual private network (VPN) products for a range of industries within the small to medium-sized enterprise market in China. This division also offers various IT security services, including consulting, implementation, management, and training. AsiaInfo-Linkage also involves in researching, designing, and developing information technology solutions and software products, as well as in upgrading the existing software products to enhance scalability and performance, and to provide added features and functions. The company was formerly known as AsiaInfo Holdings, Inc. and changed its name to AsiaInfo-Linkage, Inc. as a result of its merger with Linkage Technologies International Holdings Limited on July 1, 2010. AsiaInfo-Linkage, Inc. was founded in 1993 and is headquartered in Beijing, the Peoples Republic of China.

GILEAD SCIENCES, INC. (NASDAQ:GILD) - Gilead Sciences, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics for the treatment of life threatening diseases worldwide. Its products include Atripla, Truvada, Viread, Emtriva for the treatment of human immunodeficiency virus infection in adults; Hepsera, an oral formulation for the treatment of chronic hepatitis B; AmBisome, a amphotericin B liposome injection to treat invasive fungal infections; Letairis, an endothelin receptor antagonist for the treatment of pulmonary arterial hypertension; Ranexa for the treatment of chronic angina; Vistide, an antiviral medication for the treatment of cytomegalovirus retinitis in patients with AIDS; and Cayston, an inhaled antibiotic used as a treatment to enhance respiratory systems. The companys products also comprise Tamiflu, an oral antiviral for the treatment and prevention of influenza A and B; Macugen, an intravitreal injection for the treatment of neovascular age-related macular degeneration; and Lexiscan/Rapiscan, an injection used as a pharmacologic stress agent in radionuclide myocardial perfusion imaging. Its products under the Phase III clinical trials consist of Cobicistat, a pharmacoenhancer that is under evaluation as a boosting agent for HIV medicines; Elvitegravir, an oral integrase inhibitor being evaluated as part of combination therapy for HIV; Integrase Single-Tablet, a Quad regimen of elvitegravir, cobicistat, tenofovir disoproxil fumarate, and emtricitabine for the treatment of HIV/AIDS in treatment-naive patients; and Aztreonam for inhalation solution for the treatment of cystic fibrosis patients with Pseudomonas aeruginosa. The companys Phase II clinical trials products comprise Cicletanine, Ranolazine, and Aztreonam, as well as GS 9190, GS 9256, and GS 9451. Its Phase I clinical trial products include GS 7340, GS 5885, GS 6620, GS 9620, and GS 6624. The company was founded in 1987 and is headquartered in Foster City, California.

THERAVANCE, INC. (NASDAQ:THRX) - Theravance, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule medicines across various therapeutic areas, including respiratory disease, bacterial infections, and gastrointestinal motility dysfunction. Its key programs include VIBATIV with Astellas Pharma, Inc. approved in the United States and Canada for the treatment of adult patients with complicated skin and skin structure infections (cSSSI) caused by susceptible Gram-positive bacteria, including Staphylococcus aureus, both methicillin-resistant and methicillin-susceptible strains; RELOVAIR with GlaxoSmithKline (GSK), a Phase 3 clinical trial program for the treatment of patients with chronic obstructive pulmonary disease and/or asthma; and the Bifunctional Muscarinic Antagonist-beta2 Agonist program with GSK, which completed Phase 2a. The companys other pipeline programs under various clinical-stages comprise TD-1211, an oral peripheral Mu-opioid antagonist for the treatment of opioid-induced constipation; TD-5108 and TD-8954, 5HT-4 agonists for the treatment of gastrointestinal motility dysfunction and/or Alzheimers disease; TD-1792, an antibiotic for the treatment of serious infections caused by Gram-positive bacteria; and MARIN program (TD-9855) for the treatment of chronic pain. The company was formerly known as Advanced Medicine, Inc. and changed its name to Theravance, Inc. in April 2002. Theravance was founded in 1996 and is headquartered in South San Francisco, California.

Urologix Inc (NASDAQ:ULGX) - Urologix, Inc. develops, manufactures, and markets non-surgical catheter-based therapies for the treatment of benign prostatic hyperplasia (BPH), commonly known as an enlarged prostate. The companys products include Targis System, which comprise control units; and Prostatron System, a catheter-based treatment for BPH. Its systems utilize its Cooled ThermoTherapy technology, a targeted microwave energy combined with a cooling mechanism, which protects healthy tissue and enhances patient comfort while providing relief from the symptoms of BPH by the thermal ablation of hyperplastic prostatic tissue. The company markets its control units under the CoolWave and Targis names; and procedure kits that consist of a disposable treatment catheter, rectal thermal unit, and coolant bag under the CTC Advance, Targis, and Prostaprobe names. Urologix sells its products to urologists, ambulatory surgery centers, and hospitals through sales management, marketing support, clinical support, and mobile application specialists, as well as through direct sales representatives and distributors in the United States and internationally. The company was founded in 1991 and is based in Minneapolis, Minnesota.

SqueezeTrigger.com has built a massive database that collects, analyzes and publishes multiple proprietary trading strategies that predict price moves in stocks, commodities and currencies. The data has then been integrated into an automated trading platform which can be used to connect to a live online broker and automate your trading of each of the strategies highlighted. It is extremely powerful with lightening fast execution at a very low price. Both the trading software and SqueezeTrigger data feed are available at http://www.squeezetrigger.com

www.squeezetrigger.com monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements".

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO.

INVESTMENTS & TRADING

SqueezeTrigger -- 25 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

About SQUEEZETRIGGER.COM

WWW.SQUEEZETRIGGER.COM is a service designed to help bonafide shareholders of publicly traded US companies fight short selling. SqueezeTrigger.com has built a proprietary database that uses Threshold list feeds and short sale time and sale data from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short trades.

SQUEEZETRIGGER.COM has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2.5 billion short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data.

The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha'a"s short transactions, SQUEEZETRIGGER.COM provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.

All material herein was prepared by SQUEEZETRIGGER.COM, based upon information believed to be reliable. The information contained herein is not guaranteed by SQUEEZETRIGGER.COM to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion.

Occassionally companies pay $995.00 to purchase data for information provided in reports issued by BUYINS.NET, a company affiliated with SQUEEZETRIGGER.COM. The data service can be cancelled at any time. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SQUEEZETRIGGER.COM is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. SQUEEZETRIGGER.COM will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

SQUEEZETRIGGER.COM and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of SQUEEZETRIGGER.COM, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor.

By visiting SQUEEZETRIGGER.COM or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. Global Automated Trading Systems, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to SQUEEZETRIGGER.COM and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State.

Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. SQUEEZETRIGGER.COM does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. SQUEEZETRIGGER.COM places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.

Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SQUEEZETRIGGER.COM undertakes no obligation to update such statements.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected", "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.

Contact: Thomas Ronk, CEO www.squeezetrigger.com +1-800-715-9999 Tom@squeezetrigger.com

SqueezeTrigger is a registered trademark, Reg. No. 3,120,641